{
  "docId": "019f6b8f-600f-75e6-9598-15bc34c65b74",
  "docSlug": "jarvis-sarissa-amarin-presentation-february-2023",
  "documentTitle": "Sarissa Amarin Presentation February 2023",
  "authorId": "sarissa-amarin-presentation-february-2023",
  "authorName": null,
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": null,
  "aspectRatio": null,
  "pageNumber": 10,
  "pageCount": 37,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a 'moving the goalposts' visual metaphor (soccer goals) to illustrate the missed deadlines.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019f6b8f-600f-75e6-9598-15bc34c65b74/10",
  "deckHref": "/decks/019f6b8f-600f-75e6-9598-15bc34c65b74",
  "deckJsonHref": "/decks/019f6b8f-600f-75e6-9598-15bc34c65b74.json",
  "deckAnchorHref": "/decks/019f6b8f-600f-75e6-9598-15bc34c65b74#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.45,
        "x": 0.48,
        "y": 0.47
      },
      "kind": "callout",
      "text": "Amarin DEFA14A from February 6, 2023 now suggests 1Q23 approval",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f82672c-94e3-4411-9108-48f612b60b5c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.75,
        "y": 0.65
      },
      "kind": "image",
      "text": "Moving goalposts graphic",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74bcc021-c342-49f0-9772-f4e697c52665",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.75,
        "x": 0.07,
        "y": 0.64
      },
      "kind": "paragraph",
      "text": "Now, an update on the already partnered international territories, China, Middle-East, North Africa and Canada. In China, our partner Edding Pharm continues to expect to receive approval of VASCEPA in Mainland China and Hong Kong by the end of 2022. China is a significant market opportunity and we continue to work hard with our partner to",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0151e7f9-6bf7-4a9e-a30f-06353f9901a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.07,
        "y": 0.58
      },
      "kind": "paragraph",
      "text": "Amarin Full Year 2021 Earnings (March 2022)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9aa8d662-5506-423a-a40d-c1b1a79dcf01",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.07,
        "y": 0.31
      },
      "kind": "paragraph",
      "text": "Amarin Full Year 2020 Earnings (February 2021)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ccfa21b9-7d6f-4a31-9a46-8b2fb77eed35",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.75,
        "x": 0.07,
        "y": 0.37
      },
      "kind": "paragraph",
      "text": "Earlier this month, regulatory authorities in China, the Chinese NMPA accepted Edding's new drug application for review of VASCEPA, which is another milestone on the path to approval for Edding. Edding currently anticipates receiving approval of VASCEPA in Mainland China near the end of 2021 and also anticipates approval of VASCEPA in Hong Kong near the end of 2021.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d17545bc-0cae-4538-97b3-1afa520abec3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.03,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Source: Company earnings",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30f04fc7-2c8e-4dbe-aee5-a9370e66e959",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "The China Vascepa approval hasn't occurred as promised, now expected in 1Q23",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff947dd0-983e-4670-a1c6-3a95f1281e05",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "94bddbc3-4e4a-4fcb-a0e3-0efaf5be4c15",
      "evidence": "Highlights management's failure to meet stated timelines",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 3,
      "beatId": "b7e79be6-981f-4bdc-8870-71745aca0a8d",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradictions",
      "beatSlug": null,
      "evidence": "The presentation spends several pages exposing contradictions in Amarin's statements and actions",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}